Alzheimer’s Disease Research Request for Proposals
Alzheimer’s Disease Research, a BrightFocus Foundation program, provides research funds for U.S. domestic and international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer’s disease.
We are committed to supporting scientists from diverse backgrounds to foster creativity and innovation in addressing complex scientific challenges and strongly encourage applications from individuals who are from groups underrepresented in Alzheimer’s disease research.
FY26 Dates & Deadlines
Request for Proposals Opens
June 30, 2025
Full Proposals Due
September 29, 2025
All deadlines are 5:00 p.m. EST (Washington, D.C.) on the day of the deadline.
Program Update:
Please note that a Letter of Intent is no longer required for this program. Applicants must submit a full proposal by the stated deadline.
About the Awards
Alzheimer’s Disease Research offers two types of awards:
Standard Awards
This research grant program is restricted to new and early investigators who have obtained their MD, PhD, or equivalent degree and/or completed formal medical training/residency within the past 12 years at the time of application. The applicant must serve as the principal investigator on the project, have institutional permission to manage the award, and the key personnel associated with the proposal.
- Award Amount: $300,000
- Duration: 3 years
Postdoctoral Fellowship Awards
Must be within 5 years of degree conferral.
Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards fund projects in an established laboratory that will serve as the basis for the applicant’s independent research career.
- Award Amount: $200,000
- Duration: 2 years
Related News
4 Takeaways from Alzheimer’s Fast Track 2025
This innovative meeting hosted by BrightFocus Foundation bridges cutting-edge science, mentorship, and community building for early-career researchers.
Understanding Alzheimer’s & Exploring New Frontiers in Treatment
Watch a conversation inspired by the documentary film Taking Care and the latest research in Alzheimer’s therapies.
New Clues in the Fight Against Alzheimer’s: Q&A with Dr. Keith Hengen
During World Alzheimer’s Month, Alzheimer’s Disease Research grantee Dr. Keith Hengen joined BrightFocus’ Dr. Sharyn Rossi on Instagram Live to talk brain health—how the brain functions, why quality sleep matters, and tips to keep your brain healthy.
Targeting Genetic Triggers of Inflammation in Alzheimer’s Disease
A BrightFocus Alzheimer’s Disease Research-funded scientist is investigating how “jumping genes” may fuel brain inflammation in Alzheimer’s—and whether blocking them could prevent or slow dementia.
Home-Based Alzheimer’s Treatment Brings Care Closer to Families
A team of BrightFocus Alzheimer’s Disease Research-funded scientists is exploring how home-based brain stimulation could improve memory, mood, and daily life for people living with Alzheimer’s disease.
Inside the First International Biobank Studying Down Syndrome and Alzheimer’s
BrightFocus Alzheimer’s Disease Research-funded scientists have spent the last decade building a first-in-class initiative to study the brains of people with Down syndrome and Alzheimer’s disease.
The Early Alzheimer’s Signals We’ve Been Missing (Until Now)
Using advanced genetic sequencing, BrightFocus Alzheimer’s Disease Research-funded scientist Dr. Mark Ebbert is identifying overlooked changes in the brain that could finally unlock a way to diagnose Alzheimer’s before it begins.
New Blood Test Could Personalize Alzheimer’s Treatment Like Never Before
A new Alzheimer’s blood test may reveal how far the disease has progressed and identify who’s most likely to benefit from anti-amyloid therapies.
What Early-Life Brain Activity May Reveal About Alzheimer’s Risk
BrightFocus Alzheimer’s Disease Research grant recipient Keith Hengen, PhD, is pioneering a novel approach to identifying Alzheimer’s risk in early life, which could enable earlier diagnosis, risk reduction, and treatment.